Serum lipids as biomarkers for therapeutic monitoring of latent tuberculosis infection

European Respiratory Journal

Volumn 42, Issue 2, 2013, Pages 547-550

  Albanna, Amr S ^a   Bachmann, Kenneth ^b   White, Donald ^c   Valiquette, Chantal ^a   Menzies, Dick ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF TOLEDO   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISONIAZID; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RIFAMPICIN; TRIACYLGLYCEROL;

CHOLESTEROL BLOOD LEVEL; HUMAN; LATENT TUBERCULOSIS; LETTER; LIPID BLOOD LEVEL; LIPID METABOLISM; MULTICENTER STUDY (TOPIC); PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; APOLIPOPROTEINS A; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; FEMALE; HUMANS; ISONIAZID; LATENT TUBERCULOSIS; LIPID METABOLISM; LIPIDS; MALE; MIDDLE AGED; RIFAMPIN; YOUNG ADULT;

EID: 84882658220     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00064713     Document Type: Letter

References (10)

1. World Health Organization. Global Tuberculosis Report 2012. Geneva, WHO Press, 2012.
2. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161: S221-S247.
3. Wallis RS, Doherty TM, Onyebujoh P, et al. Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infect Dis 2009; 9: 162-172.
4. Li T, Chiang JY. Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4a and coactivators, and suppression of small heterodimer partner gene expression. Drug Metab Dispos 2006; 34: 756-764.
5. Handschin C, Meyer UA. Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR. Arch Biochem Biophys 2005; 433: 387-396.
6. O?Neill B, Callaghan N, Stapleton M, et al. Serum elevation of high-density lipoprotein (HDL) cholesterol in epileptic patients taking carbamazepine or phenytoin. Acta Neurol Scand 1982; 65: 104-109.
7. Manyam BV. Isoniazid-induced reduction of serum cholesterol. Chest 1983; 84: 120.
8. Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 2008; 118: 2047-2056.
9. Smith SJ, Cooper GR, Myers GL, et al. Biological variability in concentrations of serum lipids: sources of variation among results from published studies and composite predicted values. Clin Chem 1993; 39: 1012-1022.
10. Canadian Tuberculosis Committee (CTC). Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2008; 34: 1-13.